Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment

Noriaki Nagai,1 Fumihiko Ogata,1 Hiroko Otake,1 Yosuke Nakazawa,2 Naohito Kawasaki1 1Faculty of Pharmacy, Kindai University, Higashi-Osaka, Osaka, Japan; 2Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan Purpose: In the clinical setting, raloxifene, a second-generation selective estro...

Full description

Saved in:
Bibliographic Details
Main Authors: Nagai N, Ogata F, Otake H, Nakazawa Y, Kawasaki N
Format: article
Language:EN
Published: Dove Medical Press 2018
Subjects:
Online Access:https://doaj.org/article/43b34159ba3840e397cedcac9a13c3d7
Tags: Add Tag
No Tags, Be the first to tag this record!